Harvard Management Company’s 10x Genomics TXG Stock Holding History

Harvard Management Company’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.52M	Hold	170,000	–	–	0.15%	18
2026 Q1	$3.61M	Hold	170,000	–	–	0.2%	16
2025 Q4	$2.77M	Hold	170,000	–	–	0.13%	17
2025 Q3	$1.99M	Hold	170,000	–	–	0.09%	18
2025 Q2	$1.97M	Hold	170,000	–	–	0.14%	14
2025 Q1	$1.48M	Hold	170,000	–	–	0.13%	13
2024 Q4	$2.44M	Hold	170,000	–	–	0.14%	16
2024 Q3	$3.84M	Hold	170,000	–	–	0.22%	13
2024 Q2	$3.31M	Hold	170,000	–	–	0.2%	13
2024 Q1	$6.38M	Hold	170,000	–	–	0.4%	10
2023 Q4	$9.51M	Hold	170,000	–	–	0.8%	10
2023 Q3	$7.01M	Sell	170,000 -16,143	-9%	-$840K	0.79%	12
2023 Q2	$10.4M	Hold	186,143	–	–	1.02%	10
2023 Q1	$10.4M	Hold	186,143	–	–	1.09%	13
2022 Q4	$6.78M	Hold	186,143	–	–	0.84%	21
2022 Q3	$5.3M	Hold	186,143	–	–	0.66%	24
2022 Q2	$8.42M	Hold	186,143	–	–	0.98%	17
2022 Q1	$14.2M	Hold	186,143	–	–	1.43%	9
2021 Q4	$27.7M	Hold	186,143	–	–	2.6%	7
2021 Q3	$27.1M	Hold	186,143	–	–	1.59%	11
2021 Q2	$36.5M	Buy	186,143 +96,667	+108%	+$17.5M	2.1%	10
2021 Q1	$16.2M	Buy	+89,476	New	+$15.5M	0.9%	18

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Harvard Management Company's TXG Position: Q2 2026 in Review

Harvard Management Company held its 10x Genomics (TXG) position steady in Q2 2026 at 170,000 shares worth $6.52M. The position accounts for 0.15% of the portfolio, ranked #18.

Harvard Management Company first reported a position in TXG in Q1 2021 and has held it in 22 quarters since. The position peaked at $36.5M in Q2 2021. 391 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Harvard Management Company held 170,000 shares of 10x Genomics worth $6.52M as of Q2 2026.
Harvard Management Company left its 10x Genomics share count unchanged in Q2 2026.
10x Genomics made up 0.15% of Harvard Management Company's portfolio in Q2 2026, its #18 holding.
Harvard Management Company first reported a position in 10x Genomics in Q1 2021 and has held it in 22 quarters since.
Harvard Management Company's 10x Genomics position peaked at $36.5M in Q2 2021.
391 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Harvard Management Company's 13F filing for Q2 2026, filed 14 Aug 2026.